Fate Therapeutics Inc (FATE)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Redmile Group

Jeremy Green

13,124,427 $62,472,273 +2% 2.39%
2.
D E Shaw

D. E. Shaw

4,599,439 $21,893,330 +56% 0.02%
3. 2,282,531 $10,864,847 +38% 0%
4.
Casdin Capital

Eli Casdin

2,050,000 $9,758,000 0.85%
5.
Two Sigma Advisors

John Overdeck And David Siegel

1,817,300 $8,650,348 -3% 0.02%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.18 256,639 Large Shareholder, Director 13,135,758 2023-04-21 Filing
$5.99 20,000 Large Shareholder, Director 12,879,119 2023-04-20 Filing
$6.00 25,700 Large Shareholder, Director 12,859,119 2023-04-14 Filing
$5.43 36,631 Director 282,770 2023-01-13 Filing
$5.67 88,048 Director 246,139 2023-01-11 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.80 4,718 Officer 119,570 2023-08-18 Filing
$3.71 632 Director 9,302 2023-08-04 Filing
$4.87 3,854 Officer 41,146 2023-07-05 Filing
$4.83 5,182 Officer 124,288 2023-07-05 Filing
$5.58 3,460 Director 9,934 2023-06-14 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 11,978,558 $57,017,936 0%
2. 11,723,374 $55,803,260 0%
3. 10,313,911 $49,094,216 0%
4. 4,855,779 $23,113,508 0.32%
5. 3,379,064 $16,084,345 4.99%
News See All